<dd id="n1msx"></dd>
<th id="n1msx"></th>
    <dd id="n1msx"></dd>

    <progress id="n1msx"></progress>
    <tbody id="n1msx"></tbody>

    <button id="n1msx"><acronym id="n1msx"><input id="n1msx"></input></acronym></button>
    <th id="n1msx"></th>
    1. <tbody id="n1msx"><pre id="n1msx"></pre></tbody>

      熱烈歡迎遼寧成大生物來我公司參觀指導

      發布時間:

      2022-11-16

      作者:

      細菌培養基購買qdrishui


        遼寧成大生物股份有限公司技術與采購部,四人的小團隊,于5月26日到達青島日水,來我公司,做為期三天的參觀指導。

        遼寧成大生物股份有限公司(簡稱“成大生物”)是以引進國際領先的疫苗生產技術平臺為契機于2002年6月在沈陽成立。公司秉承“面對生命,只有責任”的理念,堅持“誠信與責任”的核心價值觀,致力于研發、生產和推廣“國際水平、國內領先”的生物制品,把公司建成備受行業尊敬的、有重要影響力的企業,目前有4千多萬劑人用狂犬病疫苗和1千多萬劑人用乙腦滅活疫苗生產能力。

       

          此次來訪參觀,從實踐出發,看到了青島日水各方面的實力,從辦公到廠房,從產品到服務,100%感受到了公司的氛圍;給對方留下了深刻印象,為以后的培養基生物制劑供應合作打下良好基礎。同時,也見證了我公司是一家極具實力的微生物培養基生產供應商。

      擴展閱讀>>遼寧成大生物股份有限公司驗廠審計結束


       

      Liaoning chengda biotechnology co., LTD. Technology and purchasing department, a small team of four, arrived in Qingdao on May 26, to visit our company for three days.
       
      Liaoning chengda biotechnology co., LTD. (hereinafter referred to as "chengda biology") was established in shenyang in June 2002 with the opportunity of introducing the internationally leading vaccine production technology platform. Companies adhering to the "in the face of life, only responsibility" concept, adhere to the "integrity and responsibility" core values, dedicated to the research, development, production and promotion of "international level and domestic leading" biological products, the company built by industry respected, influential enterprises, currently has more than 4000 people with rabies vaccine and more than 1000 doses people with je inactivated vaccine production capacity.
      超虎粉嫩自慰观看|99精品国产兔费观看久久99|高清欧美不卡一区二区三区